Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerrexpo Regulatory News (FXPO)

  • This share is currently suspended. It was suspended at a price of 28.58

Share Price Information for Ferrexpo (FXPO)

Share Price is delayed by 15 minutes
Get Live Data
28.58    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £168.16m
FXPO Live PriceLast checked at - London Stock Exchange

Intraday Ferrexpo Share Chart

Production Update

22 Dec 2014 07:00

RNS Number : 4103A
Ferrexpo PLC
22 December 2014
 



22 December 2014

 

Ferrexpo plc

("Ferrexpo", the "Group" or the "Company")

 

Production Update

 

Ferrexpo plc ("Ferrexpo", the "Company" or the "Group") today announces that its total pellet production for the 11 months ended 30 November 2014 increased by 3% to 10.2 million tonnes (11M 2013: 9.9 million tonnes). This production was not impacted by the recent difficulties in Ukraine.

 

In December 2014, total pellet production is expected to fall below plan by approximately 140 thousand tonnes as a result of reduced power availability during the peak demand hours of the day. This is due to lower domestic coal production and low stocks at coal fired power stations. Ferrexpo is currently holding pellet stocks and the Group's December shipments are expected to be unaffected.

 

The Ukrainian authorities are introducing measures to mitigate this situation including looking to import coal and electricity as well as allowing corporates to directly import electricity or generate it through tolling during the peak demand hours of the day.

 

Should the situation remain unchanged, however, Ferrexpo expects that the capacity of its processing facilities will remain at around current levels in 1Q 2015, after which it is expected to improve in 2Q 2015 when peak power demand reduces following the winter months. The Group is also actively managing the situation to minimise the impact of power reductions in co-operation with electricity generators and suppliers.

 

In 1Q 2015, in the event of continued power constraints, Ferrexpo will increase output of 65% Fe premium pellets and prioritise delivery under long term contracts. Spot sales will be at lower levels.

 

Ferrexpo notes that since 1 January 2014 the Ukrainian hryvnia has depreciated from UAH8.0 per US dollar to UAH15.0 per US dollar as of 30 November 2014 and to UAH15.8 per US dollar at the current time. This has further reduced Ferrexpo's C1 cash cost of production, which was on average US$44 per tonne in November. Ferrexpo's liquidity in Ukraine is currently being held stable to ensure operations are shielded as far as possible from further disruptions and are now sufficient to fund approximately two months of operating and capital expenditures at current exchange rates.

 

For further information contact:

 

Ferrexpo:

Ingrid McMahon

+44 207 389 8304

Maitland:

Peter Ogden

+44 207 379 5151 or +44 7793 858 211

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAAAFAFFLFAF
Date   Source Headline
29th May 20267:00 amRNSNotice of 2026 Annual General Meeting
28th Apr 20267:00 amRNSFunding Update and Delay in Financial Statements
22nd Apr 20267:00 amRNSUpdate on funding options
20th Apr 20267:00 amRNSSale of Iron Destiny and Update on Funding Options
15th Apr 20267:00 amRNSProduction Report for 1Q 2026
1st Apr 20269:41 amRNSTrading Update
9th Mar 20267:00 amRNSOperations and Corporate Update
2nd Mar 20268:20 amRNSDirector/PDMR Shareholding
24th Feb 20263:35 pmRNSUpdate regarding Ukrainian subsidiary
20th Jan 20263:39 pmRNSUpdate on operations in Ukraine
14th Jan 20267:00 amRNSProduction Report for 4Q 2025
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
14th Nov 20257:05 amRNSDirector Declaration
10th Nov 20257:00 amRNSLimited attack on power infrastructure
4th Nov 20257:00 amRNSPublication of Responsible Business Report
6th Oct 20257:00 amRNSProduction Report for 3Q 2025
11th Sep 202511:59 amRNSGeneral Meeting voting results
11th Aug 20257:00 amRNSPublication of Notice of General Meeting 2025
6th Aug 20257:00 amRNSInterim Results for six months ended 30 June 2025
7th Jul 20257:00 amRNSProduction Report for 2Q 2025
10th Jun 20254:48 pmRNSDirector/PDMR Shareholding
9th Jun 20254:35 pmRNSDirector/PDMR Shareholding
22nd May 202512:47 pmRNSResult of AGM
16th May 20255:00 pmRNSReport on Payments to Governments
15th May 202512:15 pmRNSUpdate regarding Ukrainian subsidiary
30th Apr 20257:00 amRNSLetter to shareholders re: auditor engagement
17th Apr 20255:32 pmRNSUkraine subsidiaries VAT refunds
10th Apr 20257:00 amRNSNotice of Annual General Meeting and 2024 ARA
7th Apr 20257:00 amRNSProduction Report for 1Q 2025
21st Mar 20257:00 amRNSStatement regarding Ukraine VAT refunds
19th Mar 20258:00 amRNSInternational Investment Agreements Notification
19th Mar 20257:00 amRNSFull Year Financial Results for 2024
11th Mar 20257:00 amRNSAnnouncement of Full Year 2024 Financial Results
5th Mar 20257:00 amRNSResponse to SBI Statement
4th Feb 20253:17 pmRNSUpdate regarding Ukrainian subsidiary
23rd Jan 20259:52 amRNSUpdate regarding Ukrainian Subsidiary
16th Jan 202511:30 amRNSUpdate regarding Ukrainian subsidiary
13th Jan 20257:00 amRNSResignation of Non-Executive Director
9th Jan 20257:00 amRNSProduction Report for 4Q 2024
30th Dec 20245:00 pmRNSPublication of Responsible Business Report
30th Dec 20245:00 pmRNSPublication of Climate Change Report
7th Oct 20247:00 amRNSProduction Report for 3Q 2024
19th Sep 202412:31 pmRNSGeneral Meeting voting results
12th Aug 20247:00 amRNSNotice of General Meeting 2024
5th Aug 20244:50 pmRNSUpdate on restrictions on shares in subsidiary
31st Jul 202412:28 pmRNSInterim Results for six months ended 30 June 2024
31st Jul 20247:00 amRNSInterim Results for six months ended 30 June 2024
30th Jul 20245:50 pmRNSInterim Results Advisory
8th Jul 20247:00 amRNSProduction Report for 2Q 2024 and 1H 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.